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Reverse transcriptase activity in chicken embryo fibroblast
culture supernatants is associated with particles containing
endogenous avian retrovirus EAV-0 RNA
Abstract
We have recently shown that live attenuated virus vaccines produced on chicken-derived cells contain
low levels of particle-associated reverse transcriptase (RT). In both virus and corresponding control
harvests produced on chicken embryo fibroblasts, these activities were present at significantly higher
concentrations than in the vaccines. In order to identify the putative retrovirus sequence responsible for
this activity, a novel method for the selective PCR amplification of particle-associated retrovirus RNA
that uses DNA primers complementary to the primer binding sites of the known exogenous retroviruses
in combination with an anchor primer was applied. A product of the endogenous avian retrovirus family
EAV-0, termed EAV-0(B1), was reproducibly generated with a tRNA(Trp)-derived primer from the RT
peak fraction of a sucrose density gradient run with a harvest of a live attenuated measles vaccine. In
contrast, no products were detected with primers derived from tRNA(Pro), tRNA(Lys)1,2 or
tRNA(Lys)3. In the same fraction, genomic RNA of EAV-0(B1) was demonstrated by long PCR.
Analysis of several sucrose density gradients from different harvests of various manufacturers
demonstrated accumulation of, and colocalization with, RT activity for the EAV-0(B1) RNA but not for
a chicken cellular mRNA. Synthesis of cDNA from EAV-0(B1) RNA was shown by endogenous RT
reaction. Furthermore, complexes of naturally primed EAV-0(B1) RNA with RT were demonstrated.
Taken together, these data strongly suggest that EAV-0 is able to produce virus-like particles with an
active RT.
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We have recently shown that live attenuated virus vaccines produced on chicken-derived cells contain low
levels of particle-associated reverse transcriptase (RT). In both virus and corresponding control harvests
produced on chicken embryo fibroblasts, these activities were present at significantly higher concentrations
than in the vaccines. In order to identify the putative retrovirus sequence responsible for this activity, a novel
method for the selective PCR amplification of particle-associated retrovirus RNA that uses DNA primers
complementary to the primer binding sites of the known exogenous retroviruses in combination with an anchor
primer was applied. A product of the endogenous avian retrovirus family EAV-0, termed EAV-0B1, was
reproducibly generated with a tRNATrp-derived primer from the RT peak fraction of a sucrose density gradient
run with a harvest of a live attenuated measles vaccine. In contrast, no products were detected with primers
derived from tRNAPro, tRNA1,2
Lys or tRNA3
Lys. In the same fraction, genomic RNA of EAV-0B1 was demonstrated
by long PCR. Analysis of several sucrose density gradients from different harvests of various manufacturers
demonstrated accumulation of, and colocalization with, RT activity for the EAV-0B1 RNA but not for a chicken
cellular mRNA. Synthesis of cDNA from EAV-0B1 RNA was shown by endogenous RT reaction. Furthermore,
complexes of naturally primed EAV-0B1 RNA with RT were demonstrated. Taken together, these data strongly
suggest that EAV-0 is able to produce virus-like particles with an active RT.
Live attenuated virus vaccines are successfully used world-
wide. Their contribution in preventing morbidity and mortality
is evident. However, the presence of undesired microorgan-
isms or other transmissible agents is a risk factor, since they
cannot be subjected to inactivation procedures and because
most of them are administered by parenteral injection, thus
bypassing biochemical and physical barriers such as gastric acid
or the skin. In order to avoid the release of contaminated
vaccines, intensive testing for a wide variety of specific patho-
gens is required (24).
We recently reported the systematic presence of low levels
of particle-associated reverse transcriptase (RT) in live atten-
uated virus vaccines that are produced in cells of chicken origin
(7). RT activity was detected by an ultrasensitive RT test,
named product-enhanced RT (PERT) assay, which has a de-
tection limit that is 106 to 107 times lower than that of con-
ventional RT tests (18) and is at least equivalent in sensitivity
to RNA-PCR (6). The activity in all chicken-derived vaccines
was shown to be inhibited by zidovudine (AZT)-triphosphate
and ddTTP, i.e., agents known to specifically inhibit retrovirus
reverse transcriptases. Furthermore, sucrose density banding,
ultracentrifugation, and filtration experiments suggested that
RT activity was associated with particles which banded at a
density compatible with that of retroviruses (7). The presence
of RT activity in these vaccines was quickly confirmed by sev-
eral other laboratories using related tests (25).
Based on the findings discussed above, we hypothesized that
some kind of retrovirus particles might be present in chicken
cell-derived vaccines. Since these vaccines are regularly tested
for exogenous viruses and because the activity was present in
all chicken cell-derived vaccines independent of manufacturer,
lot, or production year, an endogenous retrovirus was more
likely than an exogenous one. In order to identify this putative
virus, an efficient strategy for a selective amplification of par-
ticle-associated retrovirus RNA (PARRA) was applied. This
procedure identifies 5" R-U5 and subsequently 3" R sequences
of retrovirus particles, even at concentrations as low as 1,000
particles/ml (22).
In this study, we report the identification, in harvests of live
attenuated virus vaccines, of a retrovirus RNA which belongs
to the EAV-0 family and is enclosed in particles which contain
RT. EAV-0 elements belong to a group of endogenous avian
retroviruses which have been isolated from the genomic DNA
of line 0 chickens, a strain lacking classical subgroup E endog-
enous virus loci (ev#) (12). Our findings suggest not only that
EAV-0 proviruses are transcribed but also that genomic RNA
is packaged into retrovirus-like particles containing a func-
tional RT.
MATERIALS AND METHODS
Virus harvests and cell cultures. Virus harvests of live attenuated measles and
mumps virus were obtained from the manufacturers through the Swiss Federal
Office of Public Health. These harvests were collected from primary chicken
embryo fibroblast (CEF) cultures which were produced from 11-day-old chicken
embryos of specific-pathogen-free flocks and inoculated with seed virus. The
codes used for the different manufacturers are the same as those previously
published (7). Aliquots were stored at#70$C until use. MRC-5, a human diploid
lung cell line, was obtained from the American Type Culture Collection, Rock-
ville Md. (CCL-171). The cloned human T-cell leukemia virus type 2 (HTLV-2)
producer cell line 76D9 was from J. Jendis (our laboratory).
Sucrose gradient density banding. Virus harvest fluid (3 ml) precleared at
16,000 % g for 10 min, was pelleted at 70,000 % g for 90 min, resuspended in 100
&l of phosphate-buffered saline, and layered on a sucrose gradient (7.5 to 60%).
The gradient was ultracentrifugated at 30,000 % g for 16 h at 4$C in a Kontron
TFT32.13 rotor; fractions of 400 &l were manually collected from the top, and
their densities were determined in a Zeiss refractometer. Five microliters of each
fraction was analyzed for Mg2!-dependent RT activity by PERT assay.
PERT assay. The PERT assay, a test for the detection of extremely low levels
of RT activity, was performed as described elsewhere (7).
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PARRA. (i) cDNA synthesis. cDNA synthesis was performed in a final volume
of 15 &l containing 6 &l of sucrose gradient peak fraction; 50 &g of Dynabeads
Oligo (dT)25 (DYNAL); 10 pmol of primer cPB-Trp-10, cPB-Lys1,2-10, cPB-
Lys3-10, or cPB-Pro-10; 0.5 mM (each) deoxynucleoside triphosphate (dNTP);
0.25% Nonidet P-40 (NP-40); 15 U of RNase inhibitor (rRNasin; Promega); 200
U of SuperScript II RNaseH# RT (Gibco BRL); and 1% cDNA synthesis buffer
(Gibco BRL). The reaction was carried out at 37$C for 60 min.
(ii) Tailing of cDNA. Prior to tailing, the beads were washed with wash buffer
(20 mM Tris HCl [pH 8], 50 mM KCl), and then 25% of the cDNA-RNA hybrids
were subjected to RNase H degradation. Degradation was performed in a vol-
ume of 5 &l containing 10 mM Tris HCl (pH 7.5), 3 mM MgCl2, 50 mM KCl, 10
mM dithiothreitol (DTT), 0.005% NP-40, and 0.3 U of RNase H (Boehringer
Mannheim). The reaction was carried out at 37$C for 15 min followed by 65$C for
5 min. A volume of 5 &l containing 10 mM Tris HCl (pH 9), 50 mM KCl, 200 &M
dCTP, and 15 U of terminal deoxynucleotidyl transferase (Gibco BRL) was
added. The mixture was incubated at 37$C for 20 min followed by inactivation of
the enzyme at 65$C for 5 min.
(iii) Anchored PCR of the 5" terminal region. Two successive rounds of PCR
were performed with the Expand Long Template PCR System kit (Boehringer
Mannheim). The first round started with a total volume of 10 &l containing 1 &l
of tailing reaction mixture and 0.2 pmol of anchor primer BESII-40G. Three
initial cycles of 94$C for 30 s, 60$C for 1 min, and 68$C for 1 min (PHC-2 cycler;
Techne) were performed and then a PCR mixture containing 20 pmol of primer
BESII-40G and 40 pmol of primer cPB-Trp-16, cPB-Lys1,2-13, cPB-Lys3-13, or
cPB-Pro-13 was added to a final volume of 50 &l, followed by 35 cycles of 94$C
for 30 s, 50$C for 1 min, and 68$C for 1 min. One microliter from the first
amplification mixture was subjected to a second seminested PCR consisting of 35
cycles of 94$C for 30 s, 55$C for 1 min, and 72$C for 1 min, with 20 pmol of primer
BESII-26G; 40 pmol of primer cPB-Trp-19, cPB-Lys1,2-18, cPB-Lys3-16, or
cPB-Pro-19; and 1.25 U of Taq DNA polymerase (Perkin-Elmer).
(iv) Anchored PCR of the 3" terminal region. Two successive rounds of PCR
were performed. The first PCR round, which contained 1/15 of cDNA bound to
Dynabeads from the cDNA reaction described above (see “cDNA synthesis”), 40
pmol of primer no. 6, and 1.25 U of Taq DNA polymerase, started with three
initial cycles of 94$C for 30 s, 65$C for 1 min, and 68$C for 1 min. Then, 20 pmol
of anchor primer BESII-40T was added to a final volume of 50 &l, followed by
an additional 40 cycles of 94$C for 30 s, 50$C for 1 min, and 68$C for 1 min. One
microliter from the first amplification mixture was subjected to a second semi-
nested round for 35 cycles of 94$C for 30 s, 60$C for 1 min, and 72$C for 1 min,
with 40 pmol of nested primer no. 7 and 20 pmol of primer BESII-26G.
Sequencing. PCR products were isolated from low-melting-point gel by aga-
rase digestion (Boehringer Mannheim) according to the manufacturer’s instruc-
tions and sequenced by automated cycle sequencing on an ABI 373A DNA
sequencer (Perkin-Elmer). Sequencing primers were cPB-Trp-19 for the 5" prod-
uct and primer no. 7 for the 3" anchored PCR product.
Long PCR of viral cDNA. The first round of long PCR was performed accord-
ing to the manufacturer’s instructions for the Expand Long Template PCR kit
(Boehringer Mannheim) with the pair of primers no. 12 and no. 3 and 1/15 of
viral cDNA bound to Dynabeads from the cDNA reaction described above (see
“cDNA synthesis”). The second round of long PCR was performed with the pair
of primers no. 4 and no. 11 and 2% of the first long PCR mixture.
To demonstrate that no cellular EAV-0 DNA was bound to the beads, 1/30 of
the cDNA reaction mixture was subjected to PCR for 40 cycles of 94$C for 30 s,
65$C for 1 min, and 72$C for 1 min with primers no. 6 and no. 10.
RNA amplification of EAV-0, glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), and HTLV-2. (i) RNA hybridization. RNA from 10 &l of each sucrose
gradient fraction was hybridized together with an aliquot of HTLV-2 containing
culture supernatant for 30 min at room temperature to 50 &g of Dynabeads
Oligo (dT)25 in a final volume of 40 &l containing 50 mM HEPES (pH 7.5), 250
mM NaCl, 50 ng of bovine serum albumin, 10 mM DTT, 0.5% NP-40, and 40 U
of rRNasin. RNA bound to the beads was washed with 1% cDNA synthesis
buffer.
(ii) cDNA synthesis. RNA bound to the beads was subjected to cDNA syn-
thesis in a final volume of 20 &l, with the reagents and reaction conditions
described above. cDNA bound to the beads was washed with 1% PCR buffer.
(iii) 3" anchored PCR. For EAV-0 and HTLV-2 detection, 2 &l from the
cDNA synthesis reaction mixture was subjected to 3" anchored PCR with 1.25 U
of Taq DNA polymerase and primers BESII40-TG, no. 6, and HT-1. For chicken
GAPDH and HTLV-2 detection, 2 &l from the cDNA synthesis reaction mixture
was subjected to 3" anchored PCR with primers BESII40-TG, BESII40-T,
CHIGA-5, and HT-1. The first cycle was performed at 94$C for 15 s, 60$C for 1
min, and 72$C for 1 min, followed by 35 cycles of 94$C for 15 s, 55$C for 1 min,
and 72$C for 1 min on a Progene Cycler (Techne).
Southern blotting of amplified cDNA. Amplified cDNA (15 &l) was separated
on a 2% agarose gel and blotted to a nylon membrane (Hybond-N plus; Amer-
sham) by alkaline transfer, according to the manufacturer’s protocols. Probes
were labeled with ['-32P]dCTP as previously described (20). For EAV-0, probes
no. 7 and no. 11 were used for 3" anchored PCR [U3-R-poly(A)]; no. 2 and no.
2a were used for R-U5 PCR; and no. 5 and no. 9 were used for gag-leader PCR.
For chicken GAPDH, probes CHIGA-6 and CHIGA-6a were used for 3" an-
chored PCR. For HTLV-2, probes HT-2 and HT-2a were used for 3" anchored
PCR. Amplification products were visualized on a PhosphorImager (Molecular
Dynamics) and printed by the Adobe Photoshop program (version 2.0.1; Macin-
tosh).
Endogenous RT reaction. Reaction mixtures containing 2 &l of sucrose gra-
dient fraction no. 10; 1% cDNA synthesis buffer (Gibco BRL); 10 mM DTT; and
0%, 0.01%, or 0.4% NP-40, were preincubated at room temperature for 10 min
prior to the addition of 0.5 mM dNTPs and 20 pmol of dT15 (Boehringer
Mannheim) to a final volume of 30 &l. Inhibition of endogenous RT reaction was
performed with the addition of 0.075 mM AZT-triphosphate. For the positive
control, 20 U of SuperScript II RNaseH# RT (Gibco BRL) was added. The
reaction mixtures were incubated at 37$C for 15 min, and the reactions were
terminated by incubation at 75$C for 5 min. Five microliters of the endogenous
RT reaction was subjected to PCR with 40 pmol of primers no. 6 and BESII-
40TG, with a first cycle of 94$C for 30 s, 60$C for 1 min, and 72$C for 1 min and
a second cycle of 94$C for 30 s, 50$C for 1 min, and 72$C for 1 min, followed by
35 cycles of 94$C for 30 s, 55$C for 1 min, and 72$C for 1 min.
Association of RT with RNA template. RNA from 5 &l of sucrose gradient
fraction no. 10 was hybridized for 30 min at room temperature to 50 &g of
Dynabeads Oligo (dT)25 in a final volume of 10 &l containing 1% cDNA synthesis
buffer, 10 mM DTT, and 0.5% NP-40. RNA bound to the beads was washed with
1% cDNA synthesis buffer and incubated for 60 min in a volume of 20 &l
containing 1% cDNA synthesis buffer, 10 mM DTT, 0.005% NP-40, and either
0.5 mM dNTPs, no dNTPs, or 0.5 mM dNTPs with 20 U of SuperScript II
RNaseH# RT. cDNA bound to the beads was washed with 1% PCR buffer.
Twenty-five percent of the washed beads were subjected to PCR with 40 cycles
as described above for the endogenous RT reaction. Primers no. 1 and cPB-
Trp-19 were used for 5" R-U5 PCR, primers no. 6 and BESII-40TG were used
for 3" U3-R-poly(A) anchored PCR, primers no. 6 and no. 8 were used for
U3-R-U5 PCR, and primers no. 3 and no. 10 were used for gag-leader PCR.
Primer sequences. The primers used and their sequences are as follows:
cPB-Trp-10 (5"-AATCACGTCG-3"), cPB-Trp-16 (5"-AATCACGTCGGGGTC
A-3"), cPB-Trp-19 (5"-AATCACGTCGGGGTCACCA 3"), cPB-Lys1,2-10 (5"-
GCCCCACGTT-3"), cPB-Lys1,2-13 (5"-GCCCCACGTTGGG-3"), cPB-Lys1,2-18
(5"-GCCCCACGTTGGGCGCCA-3"), cPB-Lys3-10 (5"-AGTCCCTGTT-3"),
cPB-Lys3-13 (5"-GTCCCTGTTCGGG-3"), cPB-Lys3-16 (5"-AGTCCCTGTTC
GGGCG-3"), cPB-Pro-10 (5"-AATCCCGGAC-3"), cPB-Pro-13 (5"-AATCCCG
GACGAG-3"), cPB-Pro-19 (5"-AATCCCGGACGAGCCCCCA-3"), BESII-40G
(5"-CGCGGTGATCAGAATTCGTCGACAGGGGGGGGGGGGGGGG-3"),
BESII-26G (5"-CGCGGTGATCAGAATTCGTCGACAGG-3"), BESII-40T
(5"-GAATTCGTCGACAGGTTTTTTTTTTTTTTTTTTTTTTTTT-3"), BESII-
40TG (5"-GAATTCGTCGACAGGTTTTTTTTTTTTTTTTTTTTTTTTG-3"),
no. 1 (5"-GCCATTTTGCCGCTCATCATATTGGTGTCA-3"), no. 2 (5"-CAG
GCTCCCCTAAGCAACGAACATCACGG-3"), no. 2a (5"-GGCAACCGTGA
TGTT-3"), no. 3 (5"-GCTTAGGGGAATGAGTCGGCTGTCTGCTTG-3"), no.
4 (5"-GGCTGTCTGCTTGACGGGGCAGGAG-3"), no. 5 (5"-GGACAGAGG
GAATCTG-3"), no. 6 (5"-ATAGGCGTGATCGGGGTCTCGGGATG-3"), no.
7 (5"-CGTGTCAGGCTCCTCCCCATGTGTTAGG-3"), no. 8 (5"-GCCAAAT
ACCGAGGTGACACCAATATGATGAG-3"), no. 9 (5"-GGTGACTGCAGA
TTCC-3"), no. 10 (5"-GTCCGCGACCTCCGCCGACAGAG-3"), no. 11 (5"-C
GTGGCACGTACCTAACACATGGGGAG-3"), no. 12 (5"-CCCTTCGTGTA
CGCCCACTGGATGG-3"), HT-1 (5"-AGCGCAAGGACAGTTCAGGAGG-
3"), HT-2 (5"-GAGGTTTCAAGCCAGAGTCTAGCCGAG-3"), HT-2a (5"-GT
GCTCGGCTAGA-3"), CHIGA-5 (5"-GGAAGCAGGACCCTTTGTTGGAG-
3"), CHIGA-6 (5"-GGTGAACACTTTTATTGATGTAAGGTGG-3"), and
CHIGA-6a (5"-GAGCCACCTTACA-3"). The design of primers no. 1 to 12 was
based on the EAV-0B1 sequence and EAV-0 sequence from GenBank (accession
number M31066). The relative localization of the EAV-0-specific primers is
shown in Fig. 1. HT-1, HT-2, and HT-2a primers are based on the HTLV-2
sequence from GenBank (accession number L20734). CHIGA-5, CHIGA-6, and
CHIGA-6a are based on the chicken GAPDH sequence from GenBank (acces-
sion number K01458).
FIG. 1. Relative location and orientation of the EAV-0 specific oligonucleotide primers. The arrows indicate primers no. 1 to 12 and the cPB-Trp primer set.
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RESULTS
RT activity is present in all virus vaccine harvests of chicken
cell origin, independent of vaccine virus. It has been demon-
strated that live attenuated virus vaccines produced in chicken
cells contain RT activity (7). The starting material for vaccine
production is the so-called harvest, which is either a superna-
tant of CEF cultures or allantoic fluid of embryonated eggs
which were infected with seed virus. CEF harvests from two
manufacturers which contained live attenuated measles or
mumps virus were tested for RT activity by the PERT assay
(Fig. 2). RT activity was found to be independent of manufac-
turer and vaccine virus. CEF control harvests, i.e., culture
supernatants from uninoculated CEFs of the same lot, showed
comparable levels of RT activity, indicating that RT activity
was neither induced nor introduced by the vaccine virus. These
data are consistent with an endogenous retrovirus being the
cause of the RT activity. As expected, activity in the harvests
was higher than that in the final diluted vaccine product (7).
Interestingly, RT activity in different control harvests from the
same manufacturer varied by up to two orders of magnitude.
Amplification and sequencing of particle-associated retro-
virus RNA revealed an EAV-0 sequence. To prove the hypoth-
esis that the detected RT activity originated from a retrovirus,
an efficient strategy for a selective PARRA was applied. The
PARRA method was designed to amplify RNA sequences of
small numbers of retrovirus particles, for which no specific
sequence information other than the 18 nucleotides of the
known tRNA primer binding sites (PBs) is available (22). The
PARRA strategy is illustrated in Fig. 3. An aliquot containing
a presumed retrovirus is subjected to cDNA synthesis primed
both at the 3" end of the viral RNA with oligo(dT) magnetic
beads and at the 5" terminal region with a sequence-specific
primer complementary to the retrovirus PB (cPB primer) (Fig.
3). Since most retroviruses discovered to date have one of
only four different PBs complementary to the 3" end of
tRNAPro, tRNA3Lys, tRNA1,2Lys, or tRNATrp, four cDNA synthe-
sis reactions for each retrovirus candidate have to be per-
formed with the corresponding cPB primers. The generated
cDNA is elongated with a homopolymeric tail and subse-
quently amplified by anchored PCR (14, 16) of the 5" terminal
region. The resulting 5" R-U5 PCR product is directly se-
quenced. If the sequence at hand is of retroviral origin, the
R-poly(A) region of the viral 3" end will bind to the oligo(dT)
beads. To verify the presence of the R-poly(A) sequence, an-
chored PCR of the 3" terminal region is performed. Since the
sequenced R region is present at each end of the retrovirus
RNA genome, a sequence-specific primer located in the R
region can be used to amplify the R-poly(A) region, which can
subsequently be sequenced.
Presumed retrovirus particles from the harvest of live atten-
uated measles vaccine (manufacturer B) (7) were sedimented
by ultracentrifugation, resuspended, and banded by sucrose
gradient density banding. An aliquot of the sucrose gradient
RT peak fraction of measles virus harvest was subjected to
PARRA, which resulted in a predominant 5" amplification
product of 160 bp when cPB-Trp primers were used. Repli-
FIG. 2. RT activity in harvests of live attenuated virus vaccines determined by PERT assay. The bars show RT activity in harvests containing live attenuated measles
or mumps virus in comparison with supernatants from controls of the same lot of cells, which had not been inoculated with vaccine virus. All harvests were supernatants
of primary CEF cultures from manufacturer A or B (7). The human MRC-5 cell line was used as a negative control. A half-logarithmic dilution series of purified avian
myeloblastosis virus (AMV) RT (Boehringer Mannheim) was used as an external standard for quantification (7).
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cates of 5" terminal amplification confirmed this product (Fig.
4, lanes 1 to 4), whereas no products were obtained with primer
cPB-Lys1,2 (lanes 5 to 8), cPB-Lys3 (lanes 9 to 12), or cPB-Pro
(lanes 13 to 16). Sequencing and a subsequent similarity search
of all nucleic acid sequences in the National Center for Bio-
technology Information Entrez data bank (release 22) revealed
identity with an R-U5 sequence belonging to the EAV-0 fam-
ily. Sequencing showed that none of the other products visible
in lanes 1 to 4 (Fig. 4) was related to retrovirus elements.
To demonstrate the corresponding 3" end of this RNA se-
quence, which was named EAV-0B1, anchored PCR of the 3"
terminal region was performed. Since the predicted R region
of EAV-0 is short, primers within the EAV-0 U3 region were
designed for amplification based on the published U3 region
(9). An amplification product with a predicted length of 175 bp
was obtained (Fig. 4, lane 17). Sequencing verified that the
product was a U3-R sequence with a poly(A) tail. Comparison
of the 5" and 3" R sequences showed that they were identical
(Fig. 5). The R region was found to have a length of 19 bp, and
the U5 region measured 80 bp, contrary to the findings of
Boyce-Jacino et al., who speculated that R had a length of 21
bp and U5 had a length of 81 bp (9).
In order to demonstrate the presence of full-length RNA
(8), the entire genomic cDNA bound to the beads was ampli-
fied by long PCR (2, 10, 11). This resulted in a 5.8-kb product
(Fig. 6A), which was confirmed to be EAV-0 by molecular
cloning and sequencing (23). PCR of the U3-R-U5 long ter-
minal repeat region, a structure found only in proviral DNA,
revealed no product (Fig. 6B). This negative result thus strongly
suggests that the long PCR product originated from cDNA.
FIG. 3. Strategy to detect and identify particle-associated retrovirus RNA. The solid box represents the DNA oligonucleotide primer complementary to the PB
(cPB). The shaded circle symbolizes an oligo(dT) magnetic bead. The hatched boxes represent cDNA. Following the sequence identification of the 5" R-U5 region
(steps 1 to 4), an R-specific primer is designed to perform 3" anchored PCR (step 5) for the identification of the 3" end.
FIG. 4. Agarose gel with amplification products of the PARRA strategy.
RNA was reverse transcribed and tailed as shown in Fig. 3, and 5" R-U5 repli-
cates were amplified with the anchor primer and primers complementary to the
tryptophan (cPB-Trp; lanes 1 to 4), lysine 1,2 (cPB-Lys1,2; lanes 5 to 8), lysine 3
(cPB-Lys3; lanes 9 to 12), or proline (cPB-Pro; lanes 13 to 16) PB. The arrow
marks a repeatedly present amplification product of approximately 160 bp in
length. The band was excised, sequenced, and designated EAV-0B1. Lane 17,
anchored PCR of the 3" end starting from the same cDNA synthesis reaction
mixture as in lanes 1 to 4. M, molecular size marker pBR322 DNA-MspI digest
(New England Biolabs) (for identification of the size, see Fig. 6B).
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Colocalization of RT activity and EAV-0 RNA peak. If virus-
like particles containing RT were indeed encoded by EAV-0B1,
a colocalization of EAV-0B1 RNA and RT activity would be
expected. Sucrose gradient density banding was performed
with undiluted measles virus harvest from manufacturer B, and
each fraction of the gradient was analyzed by PERT assay.
Mg2!-dependent RT activity peaked at a density of 1.13 g/ml
(Fig. 7A). This is below 1.14 g/ml, the density at which retro-
virus particles typically band under the conditions used in our
laboratory (18). Similar results were obtained with measles
harvest from manufacturer A (data not shown).
Since the gradient was considerably contaminated with cel-
lular EAV-0 DNA, a procedure to specifically amplify RNA
was performed. Each sucrose gradient fraction was subjected
to cDNA synthesis primed by oligo(dT) magnetic beads fol-
lowed by anchored PCR of the retrovirus 3" terminal region.
To each reaction mixture, a predetermined amount of
HTLV-2 particles was added as an internal control. The EAV-
0B1 RNA accumulated in a peak which colocalized with the RT
activity peak, while the signals generated from the HTLV-2
RNA were even with all fractions. This showed that the EAV-0
product accumulation in fractions no. 6 to 12 was not due to an
artifact (Fig. 7B). As expected, no product was obtained by
amplification of the U3-R-U5 long terminal repeat, which in-
dicated that only RNA transcripts, but no cellular EAV-0
DNA, were bound to the beads (data not shown). To further
demonstrate that the accumulation of EAV-0B1 RNA at a
density of 1.13 g/ml was selective, an aliquot of the cDNA
synthesized as described above was subjected to anchored PCR
of the 3" terminal region of chicken GAPDH mRNA. In con-
trast to EAV-0B1 RNA, cellular GAPDH mRNA was evenly
distributed over the entire sucrose gradient (Fig. 7C). Accu-
mulation and colocalization of the EAV-0B1 RNA with RT
activity on sucrose gradients was also found with measles and
mumps harvests from manufacturer A (data not shown).
Synthesis of EAV-0B1 cDNA by endogenous RT reaction.
The endogenous RT reaction provides the strongest evidence
for the presence of retrovirus particles (1, 21). Under the
appropriate conditions, the virion’s own RT transcribes its own
viral RNA within the core. In order to prove the presence of
viral particles, which contain both RT and RNA, endogenous
cDNA synthesis of an aliquot of gradient fraction no. 10 was
measured after rendering the envelopes of particles permeable
by low levels of nonionic detergent to allow ingress of dNTPs
and oligo(dT)15 primers (15, 26). The resulting cDNA product
was amplified by 3" anchored PCR and analyzed by Southern
blotting. High levels of endogenous cDNA synthesis occurred
at a detergent concentration of 0.01% (Fig. 8, lane 2), whereas
low levels of cDNA synthesis were detected at 0% (intact
particles) (Fig. 8, lane 1) and 0.4% (disrupted particles) (Fig. 8,
lane 3). In the absence of dNTPs during the reverse transcrip-
tion step, no DNA could be demonstrated (Fig. 8, lane 5), i.e.,
there was no preexisting DNA and all cDNA was synthesized
de novo. The addition of AZT-triphosphate inhibited the ac-
tivity of the endogenous RT reaction.
Association of RT with EAV-0B1 RNA. To confirm the close
association of RNA and RT, we looked for complexes of
tRNA-primed RNA and RT. An aliquot of gradient fraction
no. 10 was subjected to high concentrations of nonionic deter-
gent to disrupt the particles. EAV-0B1 RNA was hybridized to
oligo(dT) beads, and unbound material was washed away. The
presumed complexes were incubated with dNTPs to allow
cDNA synthesis, and the generated cDNA was amplified by
PCR at various regions and analyzed by Southern blotting (Fig.
9). Amplification of the 5" R-U5 region revealed a strong
product (Fig. 9, lane 1), whereas the omission of dNTPs in the
reverse transcription step resulted in no amplification product.
This demonstrated that the signal generated in lane 1 (Fig. 9)
originated from de novo cDNA synthesis. 3" U3-R-poly(A)
amplification also revealed a slight product (Fig. 9, lane 4), but
amplification of the gag-leader region resulted in no product
(Fig. 9, lane 7). This showed that the synthesis of the 5" R-U5
cDNA didn’t start at the (dT)25 oligonucleotide by which the
EAV-0B1 RNA was coupled to the beads but, rather, started
upstream of the gag sequence. These results strongly suggest
FIG. 5. Nucleotide sequences of EAV-0B1. (Top) Complete 5" R-U5 sequence obtained by 5" anchored PCR. (Bottom) 3" U3-R sequence obtained by 3" anchored
PCR with primer no. 7 and the dT anchor primer. Position 1 corresponds to the first nucleotide downstream of primer no. 7 within the U3 region. The R region, whose
3" end is defined by the site of the poly(A) tail addition, has a length of 19 bp. The U5 region is 80 bp long. The sequences are identical with the published EAV-0
proviral clone g17.5 (GenBank accession number M31066). Trp-PB, tryptophan PB.
FIG. 6. (A) PCR amplification product of full-length EAV-0B1 RNA as de-
scribed in Materials and Methods. The length is approximately 5.8 kb. M1, size
marker ( DNA-HindIII digest. M2, ( DNA-PstI digest. (B) Demonstration that
the cellular U3-R-U5 EAV-0 DNA is absent. DNA was amplified by primers no.
6 and no. 10. No specific product was detectable. M3, pBR322 DNA-MspI digest
(several of the bands are identified by length, in base pairs).
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that the 5" terminal region of EAV-0B1 RNA is naturally
primed, probably with host cell-derived tRNATrp, and that it is
further associated with RT. Addition of murine leukemia virus
RT increased the cDNA synthesis at the 5" R-U5 region (Fig.
9, lane 3), indicating that not all EAV-0B1 RNA was physically
associated with endogenous RT or that the complex dissoci-
ated during the reaction procedure.
Quantification of EAV-0B1. Endpoint dilution of peak su-
crose gradient fractions no. 6 to 12 of the measles harvest
indicated that approximately 4 % 105 cDNA copies per 1 ml of
FIG. 7. Colocalization of RT activity and EAV-0B1 RNA on sucrose gradient of measles virus harvest (manufacturer B). (A) RT activity (triangles) peaked at a
sucrose density (diamonds) of 1.13 g/ml. (B) RNA-PCR of EAV-0B1 amplified by 3" anchored PCR and analyzed by Southern blotting. As an internal control, a constant
amount of HTLV-2 was added to an aliquot of each fraction; subsequently, cDNA synthesis and coamplification by 3" anchored PCR was performed. (C) RNA-PCR
of the cellular chicken GAPDH mRNA amplified by 3" anchored PCR and analyzed by Southern blotting. From each fraction, an identical volume of the cDNA
synthesized as described above was subjected to 3" anchored PCR of GAPDH and HTLV-2 cDNA. The amplification products were visualized on a PhosphorImager.
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virus harvest were present. Assuming a 50% cDNA synthesis
efficiency, the 4 % 105 cDNA molecules correspond to 8 % 105
RNA molecules or 4 % 105 virus particles, under the assump-
tion that the particles contain two copies of RNA.
DISCUSSION
We recently reported the detection of RT activity in chicken
cell-derived live attenuated virus vaccines (7); this finding was
quickly confirmed by several other groups (25). Although the
members of the World Health Organization Expert Commit-
tee on Biological Standardization agreed with the opinion that
this enzyme activity in vaccines presents no harm to vaccinees
or to the population at large, there was also agreement that a
rapid identification and biological characterization of the
agent(s) responsible for the RT activity was necessary (17, 25).
In theory, several sources of this RT activity are conceivable.
It may be associated with endogenous or exogenous retrovi-
ruses, cellular enzymes like DNA or RNA polymerases or
telomerases, or cellular elements like retrotransposons. For
several reasons, we favored a retroviral origin. The activity
could be sedimented and filtered, it peaked at a density con-
sistent with that of retroviruses, and it was inhibited by both
AZT-triphosphate and ddTTP at inhibitor concentrations that
did not affect the activity of Taq DNA polymerase. The enzyme
exhibited a preference for Mg2!, which is the preference of
avian retrovirus RT. Since the activity was present in all vac-
cines produced in cells of chicken origin, independent of man-
ufacturer, lot, or production year, we favored an endogenous
rather than exogenous virus (for an extended discussion, see
reference 7).
In our approach to identify the origin of this RT activity, we
made use of a novel method that permits the selective and
efficient amplification of particle-associated RNAs of a wide
range of retroviruses present at low concentrations (22). The
use of primers derived from tRNAPro, tRNA3Lys, tRNA1,2Lys, or
tRNATrp in this procedure permits amplification and identifi-
cation of all exogenous retroviruses identified to date, as well
as endogenous retroviruses, which are expressed and possess
one of the above-noted tRNA PBs, without a need to perform
even a single virus-specific test. Since all avian retroviruses
identified to date, including the endogenous ones, posses a
tryptophan PB, the finding that amplifications with primers
complementary to the tryptophan PB repeatedly yielded a
product, while amplification with other primers did not, was
not unexpected (Fig. 4). A 5" R-U5 sequence of the EAV-0
family, termed EAV-0B1, was repeatedly isolated from the RT
peak fraction of a sucrose gradient-purified measles virus har-
vest, while sequences of other avian retroviruses were not
found. Thus, there was no indication that the RT activity of this
vaccine was associated with a virus of the avian leukemia-
sarcoma virus (ALSV) group. A theoretical possibility that a
virus other than EAV-0 might also be associated with this
activity, namely, one which uses a tRNA PB different from the
four we tested here, cannot at present be completely ruled out.
The presence of viral genomic EAV-0B1 RNA was demon-
strated based on the redundancy of the R region at both ends
of the sequence, the 3" polyadenylation (Fig. 5), and an esti-
mated length of 5.8 kb, which is comparable to the length of
the proviral EAV-0 DNA of about 5.8 kb (19). This RNA was
specifically enriched in the sucrose gradient fractions which
contained peak RT activity (Fig. 7), it was enclosed together
with RT in the same membranated compartments (Fig. 8), and
it was naturally primed and physically associated with RT (Fig.
9). Taken together, these results provide strong evidence that
CEF-derived virus harvests, as well as the control harvests
which exhibit similar levels of RT activity (Fig. 2), contain
retrovirus-like particles that harbor both EAV-0 RNA and an
enzymatically active RT. Since there was no evidence for any
other retrovirus RNA, these findings are best compatible with
the hypothesis that an EAV-0 provirus may be capable of
producing RT-positive particles.
EAV-0 proviral sequences were first isolated from the
genomic DNA of ev# line 0 chickens, which lack endogenous
avian leukosis virus loci (12). EAV-0 sequences are present at
approximately 50 copies per haploid genome of the avian ge-
nus Gallus (13) and were shown to be transcriptionally active
during embryogenesis of line 0 chickens (9). In view of the
experimental evidence now suggesting that EAV-0 may even
be capable of producing RT-positive particles, the question
arises whether the never-identified, particle-associated RT ac-
FIG. 8. Synthesis of EAV-0B1 cDNA by endogenous RT reaction and inhi-
bition by AZT-triphosphates. A constant volume of gradient fraction no. 10 (Fig.
7) was incubated with buffer, dT15 primer, dNTPs, and various detergent con-
centrations. The generated cDNA was amplified by 3" anchored PCR and ana-
lyzed by Southern blotting. The amplification products were visualized on a
PhosphorImager. Endogenous RT activity was inhibited by the addition of the
RT-specific inhibitor AZT-triphosphate. MuLV, murine leukemia virus (Super-
Script II RNaseH# RTase [Gibco BRL]).
FIG. 9. RT is physically associated with EAV-0B1 RNA. Triplicates of a
volume of the sucrose fraction no. 10 were treated with 0.5% detergent, and viral
RNA was hybridized to oligo(dT) magnetic beads. The RNA bound to the beads
was washed and incubated in three different ways, i.e., with buffer containing
dNTPs, no dNTPs, or dNTPs with the addition of 20 U of murine leukemia virus
(MuLV) RT. The generated cDNA was amplified by PCR of the 5" R-U5 region,
anchored PCR of the 3" U3-R-poly(A) region, PCR of the gag-leader region, or
PCR of the U3-R-U5 region, as described in Materials and Methods, and ana-
lyzed by Southern blotting. The amplification products were visualized on a
PhosphorImager.
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tivity found 20 years ago by Bauer et al. in the allantoic fluid of
embryonated chicken eggs (3) and in the supernatant of pri-
mary chick embryo cell cultures derived from ALSV-free
chickens (5) is caused by the presence of EAV-0 particles. This
is probable, because Bauer et al. observed that their purified
RT-positive particles exhibited a preference for Mg2! (3) and
banded at a lower density than the retroviruses of the ALSV
group (4), which is in agreement with our results (Fig. 7) (7).
Bauer et al. further reported that their particles sedimented
more slowly and lacked infectivity (4). These properties are
consistent with the fact that several independently isolated
EAV-0 clones each showed a unique deletion of approximately
1.2 kb in env, which spanned a region extending from around
the signal peptide of the surface protein to the middle of the
coding region of the transmembrane protein (8). In addition,
the particle-associated RT activity released by chick embryo
cell cultures depended on the age of the embryo from which
the cultures were established and on the time during which the
cells had been in culture (5). These observations are compat-
ible with the transcriptional activity of EAV-0 during embry-
ogenesis of line 0 chickens (9) and provide a possible explana-
tion for the extensive variation in RT activity we found
between different harvests of the same manufacturer (Fig. 2).
The fact that Bauer et al. were unable to demonstrate an
association of their particles with RNA or endogenous RT
activity (5) seems at odds with our findings (Fig. 7 and 8). They
reasoned that their negative results could be due to the limited
amount of material, the experimental conditions applied, or
the destruction of the template during purification of the par-
ticles. The enormous increase in sensitivity achieved mean-
while by PCR-based methods could explain the discrepancy.
Additional possibilities are that not all chicken lines harbor
EAV-0 proviruses that are capable of producing particles
which contain RNA or that only a fraction of these particles
contain RNA.
Visualization of particles with a typical morphology by elec-
tron microscopy would provide further strong support for the
existence of retrovirus particles of EAV-0. However, since the
quantification of EAV-0B1 RNA indicated the presence of only
about 4 % 105 virus particles/ml, it will be almost impossible to
prove their existence by this technique. Thus, final proof will
have to come from molecular techniques.
Similarly, although our demonstration that RT and EAV-
0B1 RNA are present in the same compartment and are phys-
ically associated strongly suggests that EAV-0B1 encodes this
RT, these findings are not formal proof of this. Attempts to
clone and express the EAV-0B1 RT are in progress in order to
compare the recombinant RT with the activity found in the live
attenuated harvests.
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